D. B. L. McClelland

4.8k total citations
92 papers, 3.3k citations indexed

About

D. B. L. McClelland is a scholar working on Biochemistry, Hematology and Immunology. According to data from OpenAlex, D. B. L. McClelland has authored 92 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Biochemistry, 24 papers in Hematology and 20 papers in Immunology. Recurrent topics in D. B. L. McClelland's work include Blood transfusion and management (26 papers), Blood groups and transfusion (18 papers) and Immunodeficiency and Autoimmune Disorders (15 papers). D. B. L. McClelland is often cited by papers focused on Blood transfusion and management (26 papers), Blood groups and transfusion (18 papers) and Immunodeficiency and Autoimmune Disorders (15 papers). D. B. L. McClelland collaborates with scholars based in United Kingdom, Nigeria and United States. D. B. L. McClelland's co-authors include Timothy Walsh, D. J. C. Shearman, Michael Murphy, Christopher Hyde, S. Moore, Simon Stanworth, Susan J Brunskill, Hannah Cohen, R. R. Samson and Kate Soldan and has published in prestigious journals such as Nature, The Lancet and Gastroenterology.

In The Last Decade

D. B. L. McClelland

91 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. B. L. McClelland United Kingdom 28 1.3k 865 730 517 472 92 3.3k
Claes F. Högman Sweden 35 1.6k 1.2× 1.3k 1.5× 329 0.5× 736 1.4× 251 0.5× 139 3.5k
George J. Nemo United States 30 972 0.8× 520 0.6× 422 0.6× 584 1.1× 1.9k 4.1× 50 4.7k
J. A. J. Barbara United Kingdom 27 511 0.4× 434 0.5× 156 0.2× 483 0.9× 942 2.0× 125 2.9k
Anne F. Eder United States 29 1.5k 1.2× 741 0.9× 542 0.7× 1.3k 2.4× 194 0.4× 77 2.7k
Nareg H. Roubinian United States 28 1.2k 1.0× 698 0.8× 877 1.2× 442 0.9× 882 1.9× 78 3.0k
Patricia Charache United States 35 75 0.1× 395 0.5× 150 0.2× 46 0.1× 1.2k 2.6× 85 4.2k
A. J. Keller Australia 23 101 0.1× 333 0.4× 35 0.0× 406 0.8× 879 1.9× 63 1.9k
Helmut Ostermann Germany 36 59 0.0× 893 1.0× 477 0.7× 20 0.0× 1.4k 3.1× 134 4.1k
James Riddell United States 25 133 0.1× 121 0.1× 60 0.1× 52 0.1× 707 1.5× 72 1.9k
Kyoung Un Park South Korea 37 71 0.1× 426 0.5× 74 0.1× 19 0.0× 1.3k 2.7× 306 4.7k

Countries citing papers authored by D. B. L. McClelland

Since Specialization
Citations

This map shows the geographic impact of D. B. L. McClelland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. B. L. McClelland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. B. L. McClelland more than expected).

Fields of papers citing papers by D. B. L. McClelland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. B. L. McClelland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. B. L. McClelland. The network helps show where D. B. L. McClelland may publish in the future.

Co-authorship network of co-authors of D. B. L. McClelland

This figure shows the co-authorship network connecting the top 25 collaborators of D. B. L. McClelland. A scholar is included among the top collaborators of D. B. L. McClelland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. B. L. McClelland. D. B. L. McClelland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McClelland, D. B. L., et al.. (2007). The EU optimal blood use project. Transfusion Clinique et Biologique. 14(6). 499–503. 5 indexed citations
2.
Gibson, Brenda, Audrey Todd, Irene Roberts, et al.. (2004). Transfusion guidelines for neonates and older children. British Journal of Haematology. 124(4). 433–453. 229 indexed citations
3.
Wallis, J. P., D. Stainsby, & D. B. L. McClelland. (2002). Audit of red cell transfusion. Transfusion Medicine. 12(1). 1–9. 14 indexed citations
4.
Williamson, L. M., Sarina C. Lowe, Elizabeth M. Love, et al.. (1999). Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ. 319(7201). 16–19. 244 indexed citations
5.
Padova, Franco E. Di, Helmut Brade, G R Barclay, et al.. (1993). A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides. Infection and Immunity. 61(9). 3863–3872. 155 indexed citations
6.
McClelland, D. B. L., et al.. (1989). Deceptively Low Morbidity from Failure to Practice Safe Blood Transfusion: An Analysis of Serious Blood Transfusion Errors. Vox Sanguinis. 57(1). 59–62. 35 indexed citations
7.
McColl, Kenneth A., S. Moore, P.L. Yap, et al.. (1989). Stability of Murine Monoclonal Anti‐A, Anti‐B and Anti‐A,B ABO Grouping Reagents and A Multi‐Centre Evaluation of Their Performance in Routine Use1. Vox Sanguinis. 56(2). 122–130. 11 indexed citations
8.
McClelland, D. B. L., et al.. (1988). Book reviews. Annals of Hematology. 56(6). 256–256. 1 indexed citations
9.
Prowse, C. V., et al.. (1987). Assessment of a New Centrifugal Plasmapheresis Machine: The SPC‐600. Vox Sanguinis. 53(3). 129–134. 2 indexed citations
10.
Hornsey, V., Moira McCann, K. James, et al.. (1985). Enhancement of Factor VIII-von Willebrand Factor Ristocetin Cofactor Activity by Monoclonal Antibodies. Thrombosis and Haemostasis. 54(2). 510–524. 10 indexed citations
11.
Dawes, J., et al.. (1983). Mono clonal antibodies against 3 epitopes on human thrombin. Thrombosis and Haemostasis. 50(1). 256. 1 indexed citations
13.
Dickinson, Rebecca, H M Gilmour, & D. B. L. McClelland. (1979). Rectal biopsy in patients presenting to an infectious disease unit with diarrhoeal disease.. Gut. 20(2). 141–148. 54 indexed citations
14.
Crofton, R W, Charles G. Cochrane, & D. B. L. McClelland. (1978). Preparation of lymphoid cells from small specimens of human gastrointestinal mucosa.. Gut. 19(10). 898–906. 18 indexed citations
15.
Drife, James, et al.. (1976). Immunoglobulin synthesis in the "resting" breast.. BMJ. 2(6034). 503–506. 13 indexed citations
16.
McClelland, D. B. L.. (1976). Peyer's‐Patch‐Associated Synthesis of Immunoglobulin in Germ‐Free, Specific‐Pathogen‐Free, and Conventional Mice. Scandinavian Journal of Immunology. 5(8). 909–915. 23 indexed citations
17.
Allardyce, R. A., et al.. (1974). Appearance of Specific Colostrum Antibodies after Clinical Infection with Salmonella Typhimurium. BMJ. 3(5926). 307–309. 62 indexed citations
18.
Barnetson, R. St. C., et al.. (1973). HL-A AND DISORDERED IMMUNITY. The Lancet. 301(7794). 108–108. 17 indexed citations
19.
Parkin, Donald Maxwell, D. B. L. McClelland, R. R. O’Moore, et al.. (1972). Intestinal bacterial flora and bile salt studies in hypogammaglobulinaemia. Gut. 13(3). 182–188. 34 indexed citations
20.
Shearman, D. J. C., Donald Maxwell Parkin, & D. B. L. McClelland. (1972). The demonstration and function of antibodies in the gastrointestinal tract.. Gut. 13(6). 483–499. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026